Phase 3 Keratitis Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Parasitic Ulcer Treatment Trial
Acanthamoeba keratitis
Jeremy Keenan, MD, MPH232 enrolled17 locationsNCT06213649
Recruiting
Phase 3
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
corneal ulcerFungal Keratitis
University of California, San Francisco150 enrolled2 locationsNCT06658002
Completed
Phase 3
Clinical efficacy of Moxifloxacin in the treatment of Bacterial Keratitis: A Randomised Clinical Trial
Bacterial Keratitis
Centre for Eye Research Australia229 enrolled1 locationACTRN12606000406505